UK Innovation Map
Compare placesDifferent, not ranked.
Two or three clusters, read side by side across sectors, research, companies, capital, infrastructure, government designations and UKIZ relevance. There is no score and no ranking: British clusters are different from one another, not better or worse than one another.
Choose up to three clusters
- London
- Cambridge
- Oxford
- Manchester
- Birmingham & the West Midlands
- Bristol & Bath
- Sheffield & Rotherham
- Leeds & West Yorkshire
- Liverpool City Region
- Newcastle & the North East
- Teesside & the Humber
- Edinburgh
- Glasgow & the Central Belt
- Belfast
- Cardiff & South Wales
- Southampton & Portsmouth
- Cornwall & Plymouth
- Nottingham & Derby
- Norwich & the East
Side by side
| Dimension | Cardiff & South WalesWales | CambridgeEast of England | Liverpool City RegionNorth West |
|---|---|---|---|
| Sectors | Semiconductors, Advanced Materials, Creative Industries Supporting: Clean Energy, Advanced Manufacturing, Digital Technologies | Life Sciences, Semiconductors, Engineering Biology, Artificial Intelligence Supporting: Quantum Technologies, Advanced Materials, AgriTech & FoodTech, Digital Technologies | Life Sciences, Engineering Biology, Advanced Materials Supporting: Digital Technologies, Clean Energy, Creative Industries |
| Research |
|
|
|
| Companies |
|
| Not recorded on the map. |
| Infrastructure | Not recorded on the map. Compound semiconductor fabrication and research facilities, materials and coatings research, production studios. |
University and institute laboratories, genomics and biomedical campus facilities, and semiconductor design capability. | Not recorded on the map. University research institutes, automated chemistry facilities and port and logistics assets. |
| Capital | Public and corporate capital dominate; venture funding is limited by capital intensity. | Specialist deep tech and life science funds, university-linked funds, and corporate partners; strong at seed, thinner at growth stage relative to demand. | A modest local investor base; public and charitable research funding dominate. |
| Government programmes |
| No place-based designation recorded. |
|
| What exists | The UK's compound semiconductor cluster, combining research, fabrication and supply chain, alongside steel and coatings materials research, and a significant screen production economy. | Extreme research density for its size: life sciences and genomics, semiconductor and processor IP, engineering biology and AI, with a mature spin-out culture and specialist investors who understand long timelines. | Infection and tropical medicine research of international standing, materials chemistry and automated discovery, a large port and a Freeport designation. |
| What's missing · UKIZ interpretation | Design demand. Fabrication capability needs a pipeline of UK customers designing products that use it, and capital patient enough for semiconductor timelines. | Ownership retention. Discovery and early company formation work; the Series B onward stage frequently transfers ownership overseas. Laboratory and scale-up space, power and housing also constrain growth. | Translation capacity: strong discovery science with limited local scale-up manufacturing and limited early-stage capital to hold companies in the city region. |
| What could connect · UKIZ interpretation | South Wales fabrication connected to Bristol and Cambridge chip design and to defence, automotive and energy customers who currently source overseas. | Cambridge discovery connected to UK manufacturing and biomanufacturing capacity, and to later-stage domestic capital, so that value created here is realised here rather than acquired out of the country. | Infection and biologics research connected to North West and Teesside biomanufacturing capacity, with the port used for export rather than only import. |
| UKIZ relevance | Compound semiconductors are a genuine national specialism with a fragile ownership base. The proposed Wales mission focuses on keeping the value chain here. | Cambridge produces intellectual property at a rate few places match, and loses ownership of too much of it at Series B. The proposed Oxford-Cambridge zone concentrates on commercialisation and retention rather than on more discovery. | Discovery and manufacture here are unusually well connected, with scale-up routes that are already in use. The proposed Manchester mission treats the North West as one health and biomanufacturing geography. |
| Last verified | 15 August 2026 | 15 August 2026 | 15 August 2026 |
Proposed by UKIZ · independent · not a government designation